PanGIA Biotech Announces Peer-Reviewed Study in Diagnostics Showing 97.8% Sensitivity in Detecting Prostate Cancer Using a Urine-Based Liquid Biopsy with Machine Learning

B DELRAY BEACH, Fla., April 2, 2026 /PRNewswire/ — PanGIA Biotech, Inc. (“PanGIA”) announced a peer-reviewed clinical study published in Diagnostics, “Urine-Based Machine Learning Assay Detects…
posteditor
posteditor
Articles: 16137

Other News